MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.
IPO Year:
Exchange: NASDAQ
Website: medavail.com
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
NT 10-Q - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
10-Q - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
8-K - MedAvail Holdings, Inc. (0001402479) (Filer)
SC 13G/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13G - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13D/A - MedAvail Holdings, Inc. (0001402479) (Subject)
SC 13G/A - MedAvail Holdings, Inc. (0001402479) (Subject)
PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, announced today that it has entered into an agreement with New Orleans-based St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. St. Thomas operates eight Federally Qualified Health Centers (FQHCs), providing affordable health care to underserved communities across the New Orleans metropolitan area. "We are very excited to announce this new agreement with St. Thomas, building upon our existing infrastructure in the New Orleans area and growing our presence in the FQHC partner channel, where we see significant long-term gro
PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail" or the "Company"), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 with the Securities and Exchange Commission. The delinquency notification letter provides that, under Nasdaq rules, the Company now has 60 calendar days to submit
Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy Fund 1 also operates Oaklawn Pharmacy, which is a current MedAvail partner in Dallas, Texas. Per the terms of the agreement, the first three MedCenters are planned to be deployed at First Person
PHOENIX, Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023. A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of MedAvail's website at https://investors.medavail.com and will be archived for 90 days. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a pharmacy technology company, providing turnkey, in-clinic pharmacy services through its proprietary robotic dispensing technology,
PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023. "During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year," said Mark Doerr, Chief Executive Officer of MedAvail. "Of note, we placed an additional two revenue generating MedCenters in the field, bringing our year-to-date total to six, and we reiterate our expectation that we will place 25 net new revenue generating MedCenters in
Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution PHOENIX, Aug. 04, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, announced today that it has entered into an agreement with Dallas-based Oak Lawn Pharmacy to deploy ten M4 MedCenter kiosks across Texas. Per the terms of the agreement, Oak Lawn will deploy at least two M4 MedCenters in 2023, with the remainder to be deployed within 24 months of contract execution. Oak Lawn will fund the cost of setting up the MedCenters. "I am very pleased to welcome Oak Lawn Pharmacy as our newest
PHOENIX, Ariz., July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail" or the "Company"), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50. The reverse stock split will become effective at 5:00 p.m. Eastern time, on July 31, 2023. The Company's common stock will begin trading on a post-split basis at the market open on August 1, 2023, under the Company's existing trading symbol "MDVL". The CUSIP number for the common stock following the reverse stock split will be 58406B 202. The reverse stock split is part of the Company's plan to regain compliance w
PHOENIX, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, announced today it has successfully achieved integration between MedAvail's Remote Dispensing System® and its largest partner, Texas Health Resources. "The value proposition of the MedCenter extends to both clinics and patients alike, and the streamlined integration with Texas Health Resources via this new interface has been shown to reduce prescription dispense times by up to 36%, leading to higher patient satisfaction, while increasing prescription throughput by greater than 10%, which helps address current and worsening pharmacy staffing ch
PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023. "During the first quarter, we made good progress toward our mission of becoming a leader in the development and manufacture of pharmacy technology solutions in the short time since we announced the sale of certain of our SpotRx assets to CVS in January," said Mark Doerr, Chief Executive Officer of MedAvail. "Our pipeline continues to grow, representing a mix of both new and existing partners, and we remain on track to achieve our previously stated goal of adding 25 net new dispe
PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first quarter ended March 31, 2023, on Thursday, May 18th, after the close of the financial markets. MedAvail management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, May 18th, 2023 @ 4:30pm ETInvestor dial-in: 1- 877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13738987To access the Call me™ feature, which avoids having to wait for an operator, click here. The live a
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
4 - MedAvail Holdings, Inc. (0001402479) (Issuer)
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced the appointment of industry leaders Steven Hess to Executive Vice President, General Manager, of SpotRx and Bob McClune to Senior Vice President of Data and Analytics. "We are pleased to have Steven join our senior leadership team. Steven's extensive pharmacy experience across retail and specialty will be integral in leading our strategies to drive profitable growth and optimize our SpotRx hub pharmacy and MedCenter enabled clinic operations. We also welcome Bob to MedAvail to lead our efforts in optimizing and accelerating data exchanges with our clinic partners," said Mark Doerr, Chi
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), a technology-enabled pharmacy company, today announced that Mark Doerr, RPh, has joined the company as chief executive officer ("CEO") and director, effective January 10, 2022. Mr. Doerr succeeds Ed Kilroy, who retired as CEO and from the board of directors and is moving into an advisory role through March 31, 2022. The company also announced changes to its board of directors and reported preliminary fourth quarter and full year 2021 revenue results. Gerard van Hamel Platerink has stepped down as chairperson of the board of directors. Mr. van Hamel Platerink has served on MedAvail's board of directors since June 2012. He is succeeded by c
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail" or the "Company"), a technology-enabled pharmacy company, today announced the appointment of Ramona Seabaugh as Chief Financial Officer effective immediately. As a key member of MedAvail's executive leadership team, Ms. Seabaugh will lead the Company's financial operations. "Ramona's pharmacy industry expertise and extensive financial leadership experience will be invaluable in executing our strategy to drive operational and financial performance," said Ed Kilroy, President and Chief Executive Officer of MedAvail. "I am pleased to welcome Ramona to our team, as we continue to expand into new geographies and transform the pharmacy experience
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced the appointment of Joan O'Rourke, RN, MSN, PNP to President of SpotRx. In this newly created role, Ms. O'Rourke will oversee the continued expansion and operation of the SpotRx in-clinic operations, reporting directly to Ed Kilroy, Chief Executive Officer. "We look forward to benefiting from Joan's expertise on delivering service offerings that optimize patient adherence, improve patient satisfaction, and reduce healthcare costs. Her clinical experience, pharmacy background and sales leadership will help us accelerate the commercial strategies of SpotRx pharmacy as we continue to take
PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023. "During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year," said Mark Doerr, Chief Executive Officer of MedAvail. "Of note, we placed an additional two revenue generating MedCenters in the field, bringing our year-to-date total to six, and we reiterate our expectation that we will place 25 net new revenue generating MedCenters in
PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023. "During the first quarter, we made good progress toward our mission of becoming a leader in the development and manufacture of pharmacy technology solutions in the short time since we announced the sale of certain of our SpotRx assets to CVS in January," said Mark Doerr, Chief Executive Officer of MedAvail. "Our pipeline continues to grow, representing a mix of both new and existing partners, and we remain on track to achieve our previously stated goal of adding 25 net new dispe
PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first quarter ended March 31, 2023, on Thursday, May 18th, after the close of the financial markets. MedAvail management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, May 18th, 2023 @ 4:30pm ETInvestor dial-in: 1- 877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13738987To access the Call me™ feature, which avoids having to wait for an operator, click here. The live a
PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative technology-enabled pharmacy company, today announced that the Company will announce financial results for the first quarter ended March 31, 2023, on Monday, May 15th, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Monday, May 15th, 2023 @ 4:30 pm ETInvestor dial-in: 1-888--886-7786 (domestic) or 1-416-764-8641 (international) To access the Call me™ feature, which provides instant phone access to the event, click here. The live aud
PHOENIX, April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022. "Since assuming the role of CEO in January 2022, I have been impressed by the many growth opportunities addressable by both our pharmacy services and pharmacy technology solutions," said Mark Doerr, Chief Executive Officer of MedAvail. "However, I believe it is in the best interest of our company to balance topline growth with an alternative path that targets accelerated profitability. As such, we made the difficult decision earlier this year to restructure and
PHOENIX, April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022, on Thursday, April 13th, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, April 13th, 2023 @ 4:30pm ETInvestor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13737951To access the Call me™ feature, which avoids having to wait for an
PHOENIX, March 16, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail"), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022 on Thursday, March 30, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Call and webcast details:Thursday, March 30, 2023 @ 4:30pm ETInvestor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)Conference ID: 13736400To access the Call me™ feature, which avoids having to wait for an operat
PHOENIX, Nov. 10, 2022 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended September 30, 2022. "During the third quarter, we made significant progress on our key milestones – we achieved and exceeded our target of 100 dispensing MedCenters, delivered gross margin expansion for the second consecutive quarter, and reached savings of 26% on our cash burn rate over the fourth quarter of 2021. We are also pleased with our third quarter performance; despite some headwinds, we continued to meaningfully broaden our retail pharmacy footprint and continued to expand our technology
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today announced it will report financial results for the third quarter of 2022 on Thursday, November 10, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed by registering online for the live audio webcast on the "Investor Relations" section of MedAvail's website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event. About MedAvail MedAvail Holdings, Inc. (NASDAQ:MDVL) is a technology-enabled pharmacy organi
MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail") a technology-enabled pharmacy company, today reported financial results for the three months ended June 30, 2022. "We continued to execute on our strategic initiatives in the second quarter and are pleased to be introducing our full year revenue guidance. Our strong financial results are a testament to our focus on expanding our retail pharmacy and technology footprint, increasing utilization, and reducing costs across the enterprise," said Mark Doerr, Chief Executive Officer of MedAvail. "We are delighted by the interest in our differentiated retail pharmacy and pharmacy technology solutions and are addressing this demand through our broa